eXpanded (PrEPX) is a new study that will expand the provision of PrEP to 3,200 Victorians who have a high chance of acquiring HIV. Alfred Health is responsible for conducting the study.

WHO defines pre-exposure prophylaxis (PrEP) as the use of oral tenofovir disoproxil fumarate (TDF) or co-formulated TDF/emtricitabine (TDF/FTC) or co-formulated TDF/lamivudine …

Evaluation of preexposure (PrEP) eligibility criteria, using sexually transmissible infections as markers of human immunodeficiency virus (HIV) risk at enrollment in PrEPX, a large …

HIV pre‐exposure prophylaxis (PrEP), the use of HIV treatment medication by people at risk of HIV to reduce their risk of acquisition, has emerged over recent years as a highly‐effe­ctive HIV …

Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV transmission in people at high risk of HIV acquisition. PrEP is highly efficacious when …

May 29, 2018 · PrEPX is a prospective, population-level intervention study, designed to emulate “real world” conditions to reflect the likely clinical scenario were tenofovir and emtricitabine to …

Evaluation of preexposure (PrEP) eligibility criteria, using sexually transmissible infections as markers of human immunodeficiency virus (HIV) risk at enrollment in PrEPX, a large …

Evaluation of PrEP eligibility criteria using sexually transmissible infections as HIV risk markers at enrolment in PrEPX, a large Australian HIV pre-exposure prophylaxis trial

The PrEPX study sought to provide PrEP to 2600 people at high risk of HIV in Victoria, Australia, with the primary aim of reducing HIV transmissions in Victorian MSM by 30% and in the entire …

PrEP nurses run clinics on Monday and Tuesday and Friday each week. A sexual health specialist has a Wednesday clinic each week. This clinic is only available to people with …